Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Unicycive Therapeutics, Inc. (UNCY) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Unicycive Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1766140.
Total stock buying since 2022: $12,375.
Total stock sales since 2022: $0.
Total stock option exercises since 2022: $0.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2023 | 0 | $0 | 0 | $0 | 251,069 | $0 |
2022 | 15,000 | $12,375 | 0 | $0 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2023-07 | 0 | $0 | 0 | $0 | 251,069 | $0 |
2022-05 | 15,000 | $12,375 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2023-07-11 | Jermasek Douglas (EVP of Corporate Strategy) | Option Ex | 104,612 | .00 | 0 |
2023-07-11 | Gupta Shalabh K. (CEO) | Option Ex | 104,612 | .00 | 0 |
2023-07-11 | Gupta Pramod (EVP, Pharmaceuticals and BD) | Option Ex | 41,845 | .00 | 0 |
2022-05-16 | Schiller Brigitte | Buy | 15,000 | .82 | 12,375 |
Insider trading activities including stock purchases, stock sales, and option exercises of UNCY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Unicycive Therapeutics, Inc. (symbol UNCY, CIK number 1766140) see the Securities and Exchange Commission (SEC) website.